The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
Dr. Caldwell is an ocular disease consultant based in Johnstown, Pennsylvania. His primary focus is the diagnosis and management of anterior and posterior segment ocular disease, and he has been a ...
Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...
Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness. Alcon has received FDA approval for apraclonidine ophthalmic solution 0.125% (Brytly) redness relief ...
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs ...
Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results